You are here

Article Text

Article menu

other Versions

Download PDFPDF
DTB Select
DOACs and risk of major bleeding with concomitant medicines

https://doi.org/10.1136/dtb.2017.12.0559

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Concurrent use of amiodarone, fluconazole, rifampicin or phenytoin may increase the risk of major bleeding in some patients taking a direct oral anticoagulant (DOAC, also referred to as non-vitamin K [or novel] oral anticoagulant [NOAC]), a retrospective cohort study has found.1

    The study included data from 91,330 patients with nonvalvular atrial fibrillation (mean age 75 years) enrolled with the Taiwanese National Health Insurance Administration.1 Patients received at …

    View Full Text